The loss of MCP-1 attenuates cutaneous ischemia-reperfusion injury in a mouse model of pressure ulcer

Journal of Investigative Dermatology

Volumn 128, Issue 7, 2008, Pages 1838-1851

  Saito, Yuki ^a   Hasegawa, Minoru ^a   Fujimoto, Manabu ^a   Matsushita, Takashi ^a   Horikawa, Mayuka ^a   Takenaka, Motoi ^b   Ogawa, Fumihide ^b   Sugama, Junko ^a   Steeber, Douglas A ^c   Sato, Shinichi ^b   Takehara, Kazuhiko ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^c UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INDUCIBLE NITRIC OXIDE SYNTHASE; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DECUBITUS; DISEASE MODEL; ISCHEMIA; MACROPHAGE; MAGNET; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPERFUSION INJURY; SKIN INFLAMMATION; SKIN INJURY; TRANSGENIC MOUSE;

EID: 45349086431     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5701258     Document Type: Article

References (49)

1. Baggiolini M, Dewald B, Moser B (1994) Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines. Adv Immunol 55:97-179
2. Christopherson KS, Bredt DS (1997) Nitric oxide in excitable tissues: physiological roles and disease. J Clin Invest 100:2424-9
3. Daniel RK, Priest DL, Wheatley DC (1981) Etiologic factors in pressure sores: an experimental model. Arch Phys Med Rehabil 62:492-8
4. DiPietro LA, Polverini PJ, Rahbe SM, Kovacs EJ (1995) Modulation of JE/MCP-1 expression in dermal wound repair. Am J Pathol 146:868-75
5. Eefting F, Rensing B, Wigman J, Pannekoek WJ, Liu WM, Cramer MJ et al. (2004) Role of apoptosis in reperfusion injury. Cardiovasc Res 61:414-26
6. Fahey TJ III, Sherry B, Tracey KJ, van Deventer S, Jones WG II, Minei JP et al. (1990) Cytokine production in a model of wound healing: the appearance of MIP-1, MIP-2, cachectin/TNF and IL-1. Cytokine 2:92-9
7. Furuichi K, Wada T, Iwata Y, Kitagawa K, Kobayashi K, Hashimoto H et al. (2003) CCR2 signaling contributes to ischemia-reperfusion injury in kidney. J Am Soc Nephrol 14:2503-15
8. Garvey EP, Oplinger JA, Furfine ES, Kiff RJ, Laszlo F, Whittle BJ et al. (1997) 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase In Vitro and In Vivo. J Biol Chem 272:4959-63
9. Gerard C, Rollins BJ (2001) Chemokines and disease. Nat Immunol 2:108-15
10. Grace PA (1994) Ischaemia-reperfusion injury. Br J Surg 81:637-47
11. Hayasaki T, Kaikita K, Okuma T, Yamamoto E, Kuziel WA, Ogawa H et al. (2006) CC chemokine receptor-2 deficiency attenuates oxidative stress and infarct size caused by myocardial ischemia-reperfusion in mice. Circ J 70:342-51
12. 2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 95:7987-92
13. Ikeda M, Ikeda U, Ohkawa F, Shimada K, Kano S (1994) Nitric oxide synthesis in rat mesangial cells induced by cytokines. Cytokine 6:602-7
14. Imai T, Hieshima K, Haskell C, Baba M, Nagira M, Nishimura M et al. (1997) Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 91:521-30
15. Jiang BH, Rue E, Wang GL, Roe R, Semenza GL (1996) Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J Biol Chem 271:17771-8
16. Johnston B, Burns AR, Suematsu M, Issekutz TB, Woodman RC, Kubes P (1999) Chronic inflammation upregulates chemokine receptors and induces neutrophil migration to monocyte chemoattractant protein-1. J Clin Invest 103:1269-76
17. Kallio PJ, Wilson WJ, O'Brien S, Makino Y, Poellinger L (1999) Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway. J Biol Chem 274:6519-25
18. Kosiak M (1959) Etiology and pathology of ischemic ulcers. Arch Phys Med Rehabil 40:62-9
19. Kubes P (1995) Nitric oxide affects microvascular permeability in the intact and inflamed vasculature. Microcirculation 2:235-44
20. Kubes P (2000) Inducible nitric oxide synthase: a little bit of good in all of us. Gut 47:6-9
21. Leonard EJ, Yoshimura T (1990) Human monocyte chemoattractant protein-1 (MCP-1). Immunol Today 11:97-101
22. Ling H, Edelstein C, Gengaro P, Meng X, Lucia S, Knotek M et al. (1999) Attenuation of renal ischemia-reperfusion injury in inducible nitric oxide synthase knockout mice. Am J Physiol 277:F383-90
23. Lipton SA, Choi YB, Pan ZH, Lei SZ, Chen HS, Sucher NJ et al. (1993) A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364:626-32
24. Low QE, Drugea IA, Duffner LA, Quinn DG, Cook DN, Rollins BJ et al. (2001) Wound healing in MIP-1alpha(-/-) and MCP-1(-/-) mice. Am J Pathol 159:457-63
25. Lu B, Rutledge BJ, Gu L, Fiorillo J, Lukacs NW, Kunkel SL et al. (1998) Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med 187:601-8
26. Marber MS, Mestril R, Chi SH, Sayen MR, Yellon DM, Dillmann WH (1995) Overexpression of the rat inducible 70-kDa heat stress protein in a transgenic mouse increases the resistance of the heart to ischemic injury. J Clin Invest 95:1446-56
27. Matsushima K, Larsen CG, Dubois GC, Oppenheim JJ (1989) Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J Exp Med 169:1485-90
28. McCord JM (1985) Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 312:159-63
29. Mori R, Kondo T, Ohshima T, Ishida Y, Mukaida N (2002) Accelerated wound healing in tumor necrosis factor receptor p55-deficient mice with reduced leukocyte infiltration. FASEB J 16:963-74
30. Nathan C, Xie QW (1994) Nitric oxide synthases: roles, tolls, and controls. Cell 78:915-8
31. Parks DA, Granger DN (1986) Contributions of ischemia and reperfusion to mucosal lesion formation. Am J Physiol 250:G749-53
32. Peirce SM, Skalak TC, Rodeheaver GT (2000) Ischemia-reperfusion injury in chronic pressure ulcer formation: a skin model in the rat. Wound Repair Regen 8:68-76
33. Plumier JC, Ross BM, Currie RW, Angelidis CE, Kazlaris H, Kollias G et al. (1995) Transgenic mice expressing the human heat shock protein 70 have improved post-ischemic myocardial recovery. J Clin Invest 95:1854-60
34. Pretto EA Jr (1991) Reperfusion injury of the liver. Transplant Proc 23:1912-4
35. Qi WN, Chen LE, Zhang L, Eu JP, Seaber AV, Urbaniak JR (2004) Reperfusion injury in skeletal muscle is reduced in inducible nitric oxide synthase knockout mice. J Appl Physiol 97:1323-8
36. Quinones-Baldrich WJ, Caswell D (1991) Reperfusion injury. Crit Care Nurs Clin North Am 3:525-34
37. Reid RR, Sull AC, Mogford JE, Roy N, Mustoe TA (2004) A novel murine model of cyclical cutaneous ischemia-reperfusion injury. J Surg Res 116:172-80
38. Robson MC, Hill DP, Smith PD, Wang X, Meyer-Siegler K, Ko F et al. (2000) Sequential cytokine therapy for pressure ulcers: clinical and mechanistic response. Ann Surg 231:600-11
39. Rot A, von Andrian UH (2004) Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol 22:891-928
40. Salcido R, Donofrio JC, Fisher SB, LeGrand EK, Dickey K, Carney JM et al. (1994) Histopathology of pressure ulcers as a result of sequential computer-controlled pressure sessions in a fuzzy rat model. Adv Wound Care 7:23-4, 26, 28 passim.
41. Schulz R, Kelm M, Heusch G (2004) Nitric oxide in myocardial ischemia/reperfusion injury. Cardiovasc Res 61:402-13
42. Shen SQ, Zhang Y, Xiang JJ, Xiong CL (2007) Protective effect of curcumin against liver warm ischemia/reperfusion injury in rat model is associated with regulation of heat shock protein and antioxidant enzymes. World J Gastroenterol 13:1953-61
43. Sisco M, Liu WR, Kryger ZB, Mustoe TA (2007) Reduced upregulation of cytoprotective genes in rat cutaneous tissue during the second cycle of ischemia-reperfusion. Wound Repair Regen 15:203-12
44. Stadler I, Zhang RY, Oskoui P, Whittaker MS, Lanzafame RJ (2004) Development of a simple, noninvasive, clinically relevant model of pressure ulcers in the mouse. J Invest Surg 17:221-7
45. Suzuki Y, Deitch EA, Mishima S, Lu Q, Xu D (2000) Inducible nitric oxide synthase gene knockout mice have increased resistance to gut injury and bacterial translocation after an intestinal ischemia-reperfusion injury. Crit Care Med 28:3692-6
46. Tessier PA, Cattaruzzi P, McColl SR (1996) Inhibition of lymphocyte adhesion to cytokine-activated synovial fibroblasts by glucocorticoids involves the attenuation of vascular cell adhesion molecule 1 and intercellular adhesion molecule 1 gene expression. Arthritis Rheum 39:226-34
47. Tsuji S, Ichioka S, Sekiya N, Nakatsuka T (2005) Analysis of ischemia-reperfusion injury in a microcirculatory model of pressure ulcers. Wound Repair Regen 13:209-15
48. Woolfson RG, Millar CG, Neild GH (1994) Ischaemia and reperfusion injury in the kidney: current status and future direction. Nephrol Dial Transplant 9:1529-31
49. Yamasaki K, Edington HD, McClosky C, Tzeng E, Lizonova A, Kovesdi I et al. (1998) Reversal of impaired wound repair in iNOS-deficient mice by topical adenoviral-mediated iNOS gene transfer. J Clin Invest 101:967-71